Plain-English translation of NCT07003763 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Depression research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing electroacupuncture — a traditional treatment that combines acupuncture needles with gentle electrical stimulation — to see if it can help reduce depression in people with cancer. Depression is very common in cancer patients and can affect quality of life and treatment outcomes, but current medications often have side effects or don't work quickly enough. This trial will compare electroacupuncture to a sham (placebo) version to see if the real treatment is safe and effective.
Many cancer patients experience depression during or after their diagnosis, but standard antidepressant medications can be slow to work and may cause side effects in people already managing cancer treatment. This trial exists to explore whether this treatment offers a gentler, non-medication option that might work better for this vulnerable group.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either real electroacupuncture or a sham (placebo) version where needles are placed on areas that are not traditional acupuncture points. The real treatment uses specific acupuncture points selected for depression relief, combined with mild electrical stimulation. You will continue your regular cancer care throughout the study, and researchers will track your depression symptoms, quality of life, and overall well-being over time.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
China